Question 1

How accurate is this comprehensive inflammation panel for detecting autoimmune diseases?

Accepted Answer

Individual markers in this panel show excellent specificity, with rheumatoid factor achieving 95-96% specificity for rheumatoid arthritis diagnosis. However, diagnosis requires combining these blood test results with clinical evaluation and sometimes imaging studies to provide a complete picture. The comprehensive nature of this panel allows healthcare providers to evaluate multiple inflammatory pathways simultaneously, increasing the likelihood of detecting various autoimmune conditions.

Question 2

Can I have normal inflammatory markers but still have an autoimmune disease?

Accepted Answer

Yes, it is common for autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis to be diagnosed even when CRP levels are normal. A normal ESR does not rule out rheumatic diseases, and rheumatologists frequently treat patients with inflammatory conditions who repeatedly have normal ESR values. Additionally, many patients with lupus have minimal or no elevation in CRP even during periods of intense disease activity. This is why the comprehensive panel evaluates multiple markers to provide a more complete assessment.

Question 3

What should I do if my ANA test is positive?

Accepted Answer

A positive ANA test indicates antibodies attacking the body's own tissues, and while healthy people can occasionally test positive, high titers often suggest autoimmune disease. Healthcare providers typically consider rheumatology referral when ANA is positive at 1:160 or higher with suggestive symptoms. The other markers in this comprehensive panel help provide context for the ANA result and may indicate specific autoimmune conditions requiring specialized care.

Question 4

How often should I repeat this inflammation panel if I have been diagnosed with an autoimmune condition?

Accepted Answer

Blood tests for autoimmune conditions are usually monitored every 3-6 months or as recommended by a physician based on disease activity. Established patients with rheumatoid arthritis should monitor inflammatory markers every 3-6 months to assess treatment effectiveness. For conditions like large vessel vasculitis, routine follow-up visits including ESR and CRP measurement may be scheduled every 1-3 months during the first year and 3-6 month intervals afterward. The frequency may vary based on your specific condition and treatment response.

Question 5

Can medications affect the results of this inflammation panel?

Accepted Answer

Anti-inflammatory medications may affect CRP levels, so it's recommended to avoid them 24-48 hours before testing if possible. However, you should continue any prescribed medications unless specifically instructed otherwise by your healthcare provider. Various medications can cause elevated white blood cell counts or bone marrow suppression, which may affect CBC results. It's important to inform your healthcare provider about all medications and supplements you're taking when interpreting results.

Question 6

What is the difference between CRP and high-sensitivity CRP, and which does this panel include?

Accepted Answer

This panel includes standard CRP testing, which is preferred for detecting acute phase inflammation in autoimmune diseases, connective tissue diseases, rheumatoid arthritis, infection, or sepsis. CRP rises and falls more rapidly than ESR, making it better suited for monitoring acute conditions and treatment response. High-sensitivity CRP (hsCRP) is specifically used for cardiovascular risk assessment and measures very low levels of chronic inflammation. For autoimmune and inflammatory disease evaluation, standard CRP provides the appropriate sensitivity range.

Inflammation Panel (Comprehensive)